| 22-May-13 06:08PM | Nasdaq stocks posting largest percentage increases AP +13.44% |
| 21-May-13 06:43PM | 4 Healthcare Stock Stories For Tuesday Investment Wellness at Wall St. Cheat Sheet |
| 02:47PM | Why AcelRx Pharmaceuticals Shares Spiked Temporarily at Motley Fool |
| 11:30AM | AcelRx pain treatment meets late-stage study goals AP |
| 08:26AM | Home Deport gains on strong results optionMONSTER |
| 07:36AM | AcelRx announces positive results from Phase 3 study of Sufentanil PCA system at theflyonthewall.com |
| 07:31AM | InPlay: AcelRx: Top-line data demonstrate primary endpoint achieved in final pivotal phase 3 study of Sufentanil NanoTab PCA system for management of post-operative pain Briefing.com |
| 07:30AM | Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain PR Newswire |
| 20-May-13 06:06PM | Nasdaq stocks posting largest percentage decreases AP |
| 01:17PM | Nasdaq stocks posting largest percentage decreases AP |
| 17-May-13 06:03PM | Nasdaq stocks posting largest percentage decreases AP -7.09% |
| 16-May-13 03:20PM | AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference PR Newswire |
| 01:29PM | Nasdaq stocks posting largest percentage increases AP |
| 15-May-13 06:02PM | Nasdaq stocks posting largest percentage increases AP |
| 01:27PM | Nasdaq stocks posting largest percentage increases AP |
| 14-May-13 06:02PM | Nasdaq stocks posting largest percentage increases AP +12.16% |
| 01:04PM | ACELRX PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 10-May-13 09:34AM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online |
| 09-May-13 09:38AM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 08-May-13 07:38PM | AcelRx Pharmaceuticals' CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha -6.94% |
| 04:05PM | AcelRx Pharmaceuticals Reports First Quarter 2013 Financial Results PR Newswire |
| 10:25AM | ACELRX PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q1 2013 AcelRx Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN |
| 06-May-13 07:24AM | Drug companies attempt to make painkillers that can't be abused, WSJ reports theflyonthewall.com |
| 03-May-13 07:30AM | AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013 PR Newswire |
| 02-May-13 07:31AM | InPlay: AcelRx presents positive clinical data for the Sufentanil NanoTab PCA System at ASRA Medical meeting Briefing.com +5.05% |
| 07:30AM | AcelRx Pharmaceuticals Presents Positive Clinical Data for the Sufentanil NanoTab PCA System at ASRA Medical Meeting PR Newswire |
| 30-Apr-13 11:51AM | Major Pharma Companies Refocus R&D Efforts, Aim to Replace Lost Revenues: Expert Analyst Ian Somaiya Discusses M&A Drivers with The Wall Street Transcript Wall Street Transcript |
| 24-Apr-13 10:34PM | 3 Healthcare Stock Stories for Midweek Investment Wellness at Wall St. Cheat Sheet |
| 12:13PM | GM Sparks Electric Vehicle Program, Sprint Beats Expectations, and 3 Other Hot Stocks at Wall St. Cheat Sheet |
| 10:14AM | UPDATE 1-Higher dose of AcelRx pain drug meets trial goal at Reuters |
| 07:59AM | AcelRx pain drug shows mixed results in mid-stage trial at Reuters |
| 07:32AM | InPlay: AcelRx announces top-line data show co's ARX-04 achieves primary endpoint in dose-finding Phase 2 clinical trial Briefing.com |
| 07:30AM | Top-line Data Show AcelRx Pharmaceuticals' ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial PR Newswire |
| 13-Apr-13 02:20PM | This Week in Biotech at Motley Fool |
| 12-Apr-13 08:45AM | AcelRx Initiated at Buy and 2 Stocks at 52-Week Highs at Wall St. Cheat Sheet |
| 09-Apr-13 02:11PM | 4 Biotech Stocks Under $10 Making Big Moves at TheStreet +5.14% |
| 08-Apr-13 12:48PM | AcelRx Pharma rises as analyst starts at "Buy" AP |
| 05:42AM | AcelRx initiated with a Buy at Jefferies theflyonthewall.com |
| 21-Mar-13 04:47AM | Obagi Medical Products Acquired Wednesday, These Biotechs May Be Next at Seeking Alpha +5.32% |
| 19-Mar-13 08:32AM | AcelRx Pharmaceutical's Potential Billion-Dollar Treatment Under The Radar at Seeking Alpha |
| 16-Mar-13 01:04PM | ACELRX PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 13-Mar-13 06:48PM | New Star Analyst Rankings for AcelRx Pharmaceuticals, Inc. StarMine |
| 02:01PM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online |
| 12-Mar-13 07:13PM | AcelRx Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 05:28PM | ACELRX PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 04:05PM | AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2012 Financial Results PR Newswire |
| 07:07AM | Q4 2012 AcelRx Pharmaceuticals, Inc. Earnings Release - Time Not Supplied CCBN |
| 11-Mar-13 03:26PM | Small Pharmas With Imminent Catalysts For March 2013 at Seeking Alpha |
| 07-Mar-13 07:30AM | AcelRx Pharmaceuticals to Hold Fourth Quarter 2012 Financial Results Conference Call and Webcast on March 12, 2013 PR Newswire -6.23% |
| 06-Mar-13 04:39PM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +6.85% |
| 02:46PM | AcelRx Pharmaceuticals' CEO Presents at Cowen and Company 33rd Annual Health Care Conference - Conference Call Transcript at Seeking Alpha |
| 05-Mar-13 07:22PM | On The Fly: After Hours Movers theflyonthewall.com |
| 05:39PM | 4 Healthcare Stock Stories for Tuesday Investment Wellness at Wall St. Cheat Sheet |
| 08:36AM | Ascena spikes with strong quarter optionMONSTER |
| 08:36AM | Ascena pops on strong results optionMONSTER |
| 04-Mar-13 07:11PM | On The Fly: After Hours Movers theflyonthewall.com |
| 07:11PM | AcelRx post-operative pain treatment meets late-stage study goal at Reuters |
| 06:25PM | AcelRx pain treatment meets late-stage study goal at Reuters |
| 06:01PM | InPlay: AcelRx: Top-line data show primary endpoint achieved in pivotal phase 3 study of Sufentanil NanoTab PCA system for post-operative pain in major open abdominal surgery patients Briefing.com |
| 06:00PM | AcelRx Top-line Data Show Primary Endpoint Achieved in Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Post-Operative Pain in Major Open Abdominal Surgery Patients PR Newswire |
| 27-Feb-13 07:30AM | AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences PR Newswire |
| 19-Feb-13 07:32AM | InPlay: AcelRx provides clinical trial updates; continued progress towards nda submission for sufentanil NanoTab PCA System in Q3 2013 Briefing.com |
| 07:30AM | AcelRx Pharmaceuticals Provides Clinical Trial Updates PR Newswire |
| 07:19AM | 3 Speculative Healthcare Companies With Very High Insider Ownerships at Seeking Alpha |
| 12-Feb-13 04:32PM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex EDGAR Online |
| 07:40AM | InPlay: AcelRx Appoints Adrian Adams to Board of Directors as Chairman Briefing.com |
| 01:41AM | Largest Nasdaq Short Interest Percent Decreases as of Jan. 31 at Bloomberg |
| 01:41AM | Largest Nasdaq Short Interest Percent Decreases as of Jan. 31 at Bloomberg |
| 11-Feb-13 04:46PM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 03:19AM | Small Pharma Watch List: Week Of February 11th, 2013 at Seeking Alpha |
| 04-Feb-13 07:16AM | Coverage initiated on AcelRx by MLV & Co Briefing.com |
| 06:00AM | Imminent Catalysts Should Keep Investor Interest Alive For These Pharmaceuticals - Part II at Seeking Alpha |
| 01-Feb-13 01:09PM | 5 Stocks Poised for Breakouts at TheStreet |
| 31-Jan-13 11:58AM | Foresite Capital raises $100M for healthcare fund at bizjournals.com |
| 08:01AM | Foresite Capital Management Closes $100 Million Growth Capital Fund to Finance Late-Stage Healthcare Companies Marketwire |
| 29-Jan-13 08:31PM | Coverage initiated on AcelRx by Mizuho Briefing.com |
| 25-Jan-13 06:04PM | Nasdaq stocks posting largest percentage decreases AP |
| 03:49PM | ACELRX PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online |
| 01:17PM | Nasdaq stocks posting largest percentage decreases AP |
| 24-Jan-13 10:32AM | 3 Stocks Near 52-Week Highs Worth Selling at Motley Fool |
| 18-Jan-13 02:18PM | FDA Approval for Santarus' Uceris Zacks +7.60% |
| 17-Jan-13 04:08PM | Synergy/Callisto Merger Approved Zacks |
| 15-Jan-13 01:52PM | 3 Pharma Stocks Under $5 Trading Higher at TheStreet +8.15% |
| 14-Jan-13 11:36AM | 'Top Of The Class' Small Pharma Investments For 2013 at Seeking Alpha |
| 22-Dec-12 09:00AM | AcelRx Pharma: Pain Drug Developer With A Pair Of Q1 2013 Phase III Catalysts at Seeking Alpha |
| 17-Dec-12 08:23AM | 3 Small Pharma Companies With Major Catalysts In 2013 at Seeking Alpha |
| 14-Dec-12 12:16PM | AcelRx Pharmaceuticals Announces Exercise of Option to Purchase Additional Shares PR Newswire +5.70% |
| 12:13PM | InPlay from Briefing.com Briefing.com |
| 11:34AM | InPlay from Briefing.com Briefing.com |
| 10:59AM | InPlay from Briefing.com Briefing.com |
| 10:22AM | InPlay from Briefing.com Briefing.com |
| 09:45AM | InPlay from Briefing.com Briefing.com |
| 08:59AM | InPlay from Briefing.com Briefing.com |
| 08:33AM | InPlay from Briefing.com Briefing.com |
| 07:55AM | InPlay from Briefing.com Briefing.com |
| 07:32AM | InPlay: AcelRx Present top-line data from Phase 3 study of Sufentanil NanoTab PCA System vs. IV PCA Morphine; Phase 3 clinical trial demonstrate that the Sufentanil NanoTab PCA System was non-inferior Briefing.com |
| 07:30AM | AcelRx to Present Top-Line Data from Phase 3 Study of Sufentanil NanoTab® PCA System vs. IV PCA Morphine at the 66th Annual PostGraduate Assembly in Anesthesiology held in New York City PR Newswire |
| 10-Dec-12 06:02PM | Nasdaq stocks posting largest volume increases AP |
| 07-Dec-12 06:05PM | Nasdaq stocks posting largest volume increases AP |
